1. Home
  2. BAND vs RAPP Comparison

BAND vs RAPP Comparison

Compare BAND & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAND
  • RAPP
  • Stock Information
  • Founded
  • BAND 2000
  • RAPP 2022
  • Country
  • BAND United States
  • RAPP United States
  • Employees
  • BAND N/A
  • RAPP N/A
  • Industry
  • BAND Computer Software: Prepackaged Software
  • RAPP
  • Sector
  • BAND Technology
  • RAPP
  • Exchange
  • BAND Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • BAND 473.2M
  • RAPP 439.4M
  • IPO Year
  • BAND 2017
  • RAPP 2024
  • Fundamental
  • Price
  • BAND $18.09
  • RAPP $27.10
  • Analyst Decision
  • BAND Buy
  • RAPP Strong Buy
  • Analyst Count
  • BAND 6
  • RAPP 4
  • Target Price
  • BAND $20.80
  • RAPP $37.00
  • AVG Volume (30 Days)
  • BAND 262.3K
  • RAPP 1.6M
  • Earning Date
  • BAND 10-30-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • BAND N/A
  • RAPP N/A
  • EPS Growth
  • BAND N/A
  • RAPP N/A
  • EPS
  • BAND N/A
  • RAPP N/A
  • Revenue
  • BAND $758,106,000.00
  • RAPP N/A
  • Revenue This Year
  • BAND $2.48
  • RAPP N/A
  • Revenue Next Year
  • BAND $13.24
  • RAPP N/A
  • P/E Ratio
  • BAND N/A
  • RAPP N/A
  • Revenue Growth
  • BAND 14.51
  • RAPP N/A
  • 52 Week Low
  • BAND $11.33
  • RAPP $6.43
  • 52 Week High
  • BAND $23.00
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • BAND 71.03
  • RAPP 65.10
  • Support Level
  • BAND $14.97
  • RAPP $22.06
  • Resistance Level
  • BAND $18.63
  • RAPP $42.27
  • Average True Range (ATR)
  • BAND 0.73
  • RAPP 3.15
  • MACD
  • BAND 0.28
  • RAPP 0.66
  • Stochastic Oscillator
  • BAND 84.89
  • RAPP 46.11

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: